Date: Apr 28, 2022 01:00 PM - 02:00 PM
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To learn more about the specific program information, including universal activity numbers (UAN's) and learning objectives, please expand the modules below. Following successful completion of an evaluation, CE credit will be automatically reported to NABP through the CPE Monitor system, using the NABP ePID numbers and date of birth (MMDD) stored in participants' user profiles. Follow this link to learn more about CPE Monitor and the credit reporting process » Participants are responsible for ensuring receipt of credit; no credit can be corrected or awarded if more than 60 days have passed from the date of the event or if the home study is expired.
It is the policy of St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating in this program are expected to disclose to the program audience any real or apparent conflicts of interest related to the content of the presentation.
- Identify new molecular and biological entities that entered the U.S. drug market in the past year (excluding diagnostic compounds).
- Describe each agent’s mechanism of action, dosage, adverse reactions, contraindications, and drug interaction profile.
- List special patient instruction and monitoring parameters for each of these agents.
Erin Hennessey, Pharm.D., BCPS
Golden Peters, Pharm.D., BCPS